Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cadila Health
Cadila Health
BSE: 532321NSE: CADILAHCISIN: INE010B01027

13th-Feb-2020 11:38Source: BSE

Cadila Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed a copy of press release dated February 13, 2020 titled ''Zydus receives final approval from the USFDA for Mesalamine Suppositories for rectal use, 1000 mg''.

Sections
Follow us on